SIRPA and neoplasm: Consistent with our observations, we noted a clear increase in the prevalence of SIRPA+MSR1+-expressing macrophage subpopulations in tumour tissues (77.3% of all macrophages) compared with normal tissues (24.6% of all macrophages) (figure 6G).